ModiQuest B.V. Information

ModiQuest B.V. develops novel therapeutics for Rheumatoid Arthritis, and other inflammatory diseases, using recombinant antibody technology. ModiQuest B.V. is activily looking for partners to co-develop or outlicense several therapeutic leads for Rheumatoid Arthritis. Current leads: -anti inflammatory fully human antibody family -family of anti inflammatory peptides

Website	http://www.modiquest.com
Revenue	$6.1 million
Employees	2 (1 on RocketReach)
Founded	2004
Address	Waalbandijk 119, Nijmegen, Gelderland 6541 AK, NL
Phone	+31 412 846 000
Industry	Biotechnology Research, Consumer Services General, Consumer Services
Web Rank	30 Million
Keywords	Inflammatory Disease Treatment, Novel Therapeutics, Antibody Engineering, Therapeutic Drug Development, Pharmaceutical Development, Immunology Research, Autoimmune Disease Treatment, Pharmaceutical Research, Biotechnology, Drug Discovery, Biopharmaceutical, Partnering Opportunities, Co-Development, Clinical Development, Research And Development, Drug Licensing
Competitors	Thermo Fisher Scientific, MilliporeSigma, R&D Systems, abcam, BioLegend, BD Biosciences, MilliporeSigma, PEPROTECH EC LTD, Invitrogen, Cell Signaling Technology (CST) +41 more (view full list)
SIC	SIC Code 722 Companies, SIC Code 72 Companies
NAICS	NAICS Code 541921 Companies, NAICS Code 54192 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 5419 Companies